How often do you find yourself reading about successful IPOs? In my experience, not very often. Most business media outlets prefer to cover train wrecks. They're sexier. While bad IPOs may get all the press, let's see if we can find a good one.

IN PICTURES: Eight Ways To Survive A Market Downturn

Case in point, Fortress Investment Group (NYSE:FIG), the first global alternative asset manager listed on the New York Stock Exchange. A Fortune magazine article reported that David Swensen, Chief Investment Officer of the Yale Endowment Fund, believes the five principles at Fortress are notoriously greedy, leaving regular investors with table scraps while the partners make out like bandits. This seems like a "bad" IPO and its numbers don't make it seem any better.

Failure To Deliver
In its 2007 prospectus, Fortress brags about a 98.6% compounded annual growth rate in assets under management between December 31, 2001 and September 30, 2006. Since going public in February 2007, this number actually shrank from $29.9 billion in September 2006 to $29.5 billion at the end of 2008. A little more than two years out of the gate and FIG is already in the dumpster.

New investors who bought a piece of the offering clearly are wishing they didn't. Priced at $18.50, it's now trading below $4.

Only Nomura Investment Managers seems to see light at the end of the tunnel. Despite being underwater by about $675 million, it bought another 5.4 million shares in a secondary offering in May for $27 million. That's putting a great deal of faith in five people who already banked $1.66 billion prior to the IPO and still hold $1.3 billion in stock despite a two-year, 75% drop in its stock price.

For those doubting the Fab Five's ability to get the job done, you could always take a look at other overpaid hedge fund companies like Blackstone Group (NYSE:BX) and GLG Partners (NYSE:GLG). They too have failed to deliver.

Good Offers Tough To Find
A good IPO is an offering that balances the needs of existing investors with those of new ones. By doing so, everyone wins. Anything less is irresponsible. Corporate finance, M&A and all other fundraising professionals suffer as a result.

One IPO that does a nice job meeting investors needs is Alnylam Pharmaceuticals (Nasdaq:ALNY), a developer of therapeutic drugs based on RNA interference, which essentially acts as an agent to silence certain genes. Current drugs in development include those for age-related macular degeneration and Parkinson's disease. The company is not yet making money, but it's getting close.

In 2006, sales for Alnylam were $27 million with a $34.6 million loss. Two years later, it generated $96.2 million in sales with a net loss of $26.2 million. With a little luck, it could break through into the profit zone sometime in 2010.

On June 10, both Roth and Jefferies & Co. initiated coverage of the biopharmaceutical newbie with a "buy" rating. Why not? Its stock is up 260% since going public. That's much better than similarly valued pharmaceutical firms Medarex (NYSE:MRX) and Medicis Pharmaceutical (Nasdaq:MEDX).

However, the most impressive finding is that the spread between what new IPO investors paid ($6 per share) and existing ones ($4.48 per share) was only 25%, representing a true partnership. Fortress only wishes it could say the same.

The Bottom Line
Good IPOs are win/win situations like Alnylam Pharmaceuticals. IPOs like Fortress, Blackstone Group and other asset management offerings only benefit the favored few. Staying away from them could mean a more secure financial future. (Read Hedge Funds' Higher Returns Come At A Price for more on this topic.)

Related Articles
  1. Mutual Funds & ETFs

    The Democratization of the Hedge Fund Industry

    The coveted compensations of hedge fund managers are protected by barriers of entry to the industry, but one recent startup is working to break those barriers.
  2. Professionals

    A Day in the Life of a Hedge Fund Manager

    Learn what a typical early morning to late evening workday for a hedge fund manager consists of and looks like from beginning to end.
  3. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  4. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  5. Investing Basics

    How to Deduct Your Stock Losses

    Held onto a stock for too long? Selling at a loss is never ideal, but it is possible to minimize the damage. Here's how.
  6. Financial Advisors

    Are Alternatives Right for Your Portfolio?

    Alternative investments are increasingly making their way into retail investors' portfolios. Are they a good fit?
  7. Economics

    Is Wall Street Living in Denial?

    Will remaining calm and staying long present significant risks to your investment health?
  8. Stock Analysis

    When Will Dick's Sporting Goods Bounce Back? (DKS)

    Is DKS a bargain here?
  9. Investing News

    How AT&T Evolved into a Mobile Phone Giant

    A third of Americans use an AT&T mobile phone. How did it evolve from a state-sponsored monopoly, though antitrust and a technological revolution?
  10. Stock Analysis

    Home Depot: Can its Shares Continue Climbing?

    Home Depot has outperformed the market by a wide margin in the last 12 months. Is this sustainable?
  1. Can hedge funds trade penny stocks?

    Hedge funds can trade penny stocks. In fact, hedge funds can trade in just about any type of security, including medium- ... Read Full Answer >>
  2. Are hedge funds regulated by FINRA?

    Alternative investment vehicles such as hedge funds offer investors a wider range of possibilities due to certain exceptions ... Read Full Answer >>
  3. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  4. Can hedge fund returns be replicated?

    You can replicate hedge fund returns to a degree but not perfectly. Most replication strategies underperform hedge funds ... Read Full Answer >>
  5. Can foreign investors invest in US hedge funds?

    U.S. hedge funds are open to accredited investors. When they distribute profits to investors, those proceeds are taxed at ... Read Full Answer >>
  6. Do hedge funds manipulate stock prices?

    Some economics professors think there is evidence of manipulation of certain stocks by hedge funds on key reporting days. ... Read Full Answer >>

You May Also Like

Trading Center